Korean J Parasitol.  2007 Jun;45(2):111-114. 10.3347/kjp.2007.45.2.111.

Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand

Affiliations
  • 1Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. tmsks@mahidol.ac.th
  • 2Department of Appropriate Technology Development and Transfer, Research Institute, International Medical Center of Japan, Japan.
  • 3Roll Back Malaria Department, World Health Organization, Switzerland.

Abstract

Chloroquine remains the drug of choice for the treatment of vivax malaria in Thailand. Mixed infections of falciparum and vivax malaria are also common in South-East Asia. Laboratory confirmation of malaria species is not generally available. This study aimed to find alternative regimens for treating both malaria species by using falciparum antimalarial drugs. From June 2004 to May 2005, 98 patients with Plasmodium vivax were randomly treated with either artemether-lumefantrine (n = 47) or chloroquine (n = 51). Both treatments were followed by 15 mg of primaquine over 14 days. Adverse events and clinical and parasitological outcomes were recorded and revealed similar in both groups. The cure rate was 97.4% for the artemether-lumefantrine treated group and 100% for the chloroquine treated group. We concluded that the combination of artemether-lumefantrine and primaquine was well tolerated, as effective as chloroquine and primaquine, and can be an alternative regimen for treatment of vivax malaria especially in the event that a mixed infection of falciparum and vivax malaria could not be ruled out.

Keyword

Plasmodium vivax; vivax malaria; chloroquine; artemether-lumefantrine; Thailand

MeSH Terms

Adolescent
Aged
Animals
Antimalarials/adverse effects/*therapeutic use
Artemisinins/adverse effects/*therapeutic use
Chloroquine/adverse effects/*therapeutic use
Drug Therapy, Combination
Ethanolamines/adverse effects/*therapeutic use
Female
Fluorenes/adverse effects/*therapeutic use
Humans
Malaria, Vivax/*drug therapy
Male
Middle Aged
Parasitemia
Plasmodium vivax/drug effects
Primaquine/therapeutic use
Thailand
Treatment Outcome
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr